A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients ...

MSK radiation oncologist Dr. Nadeem Riaz and colleagues discovered that bacteria inside tumors can undermine the effects of immunotherapy. In cancer research, failure can lead to an important ...

Tumor hypoxia on 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) may serve as a reliable clinical biomarker of distant metastasis risk for patients with head and neck squamous cell ...

A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to ...

The concept that tumor responses predict survival has been acknowledged for many cancer types and has led to accelerated approval of many cancer drugs. The study in Cancer Cell, which had 41 evaluable ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, affecting over half a million people each year and causing about 300,000 ...

Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and successfully eliminated 50% of the tumors in model animals. This study was led ...